Detalles de la búsqueda
1.
Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer.
N Engl J Med
; 389(6): 504-513, 2023 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37379158
2.
Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients.
Radiol Oncol
; 50(1): 73-9, 2016 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27069452
3.
Risk factors for positive margins in conservative surgery for breast cancer after neoadjuvant chemotherapy. / Factores de riesgo de afectación de los márgenes quirúrgicos en la cirugía conservadora del cáncer de mama tras quimioterapia neoadyuvante.
Cir Esp
; 94(7): 379-84, 2016.
Artículo
en Inglés, Español
| MEDLINE | ID: mdl-27158077
4.
Software BreastAnalyser for the semi-automatic analysis of breast cancer immunohistochemical images.
Sci Rep
; 14(1): 2995, 2024 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38316810
5.
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 25(3): 233-243.e8, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38105153
6.
Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05).
J Clin Oncol
; 41(28): 4478-4485, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37603816
7.
Immunogenicity of COVID-19 vaccines in lung cancer patients.
Lung Cancer
; 184: 107323, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37639820
8.
Liquid biopsy: the value of different bodily fluids.
Biomark Med
; 16(2): 127-145, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35073730
9.
Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence.
Eur J Intern Med
; 100: 33-45, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35227541
10.
PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients.
Clin Lung Cancer
; 23(3): e243-e246, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34393061
11.
Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis.
Oncol Ther
; 10(1): 167-184, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35032007
12.
Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations.
Eur J Cancer
; 167: 142-148, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35307254
13.
Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study.
Transl Lung Cancer Res
; 11(1): 53-63, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35242627
14.
Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2-positive breast cancer?
Virchows Arch
; 479(4): 853-857, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33934230
15.
Lung cancer patients with COVID-19 in Spain: GRAVID study.
Lung Cancer
; 157: 109-115, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34016490
16.
Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial.
J Immunother Cancer
; 9(8)2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34446577
17.
Immune-Related Adverse Events and Corticosteroid Use for Cancer-Related Symptoms Are Associated With Efficacy in Patients With Non-small Cell Lung Cancer Receiving Anti-PD-(L)1 Blockade Agents.
Front Oncol
; 10: 1677, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33014837
18.
Evaluation of MRI accuracy after primary systemic therapy in breast cancer patients considering tumor biology: optimizing the surgical planning.
Radiol Oncol
; 53(2): 171-177, 2019 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31104001
19.
Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution.
Breast Cancer (Dove Med Press)
; 11: 29-42, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30643452
20.
Correction to: Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2positive breast cancer?
Virchows Arch
; 479(4): 859, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34117906